Representing RDD Pharma in a merger with a Nasdaq traded company

Partners Ofer Ben-Yehuda, Amir Iliescu and Doron Mutai & associates Daniel Kariv, Ofer Filhaber and Roni Lifshitz represented RDD Pharma in a merger transaction of the Nasdaq traded company Innovate Biopharmaceuticals Inc.; the new name of the merged company is 9 Merers Biopharma Inc.

In addition, a third company was also acquired and 22M USD was raised in new financing that was led by Orbimed Advisors, LLC.

Read the full article

Related News

HIGH TECH

Watch: Future Ready, Trends and Challenges in Emerging Technologies

Read More
Aerospace & Aviation
Drone

New Civilian Drone Regulations: Israel Moves One Step Closer to its Own Version of Part […]

Read More
HIGH TECH

Representation of Butterfly Medical in securing $7 million for their round B series

Read More
HIGH TECH

Representation of Aurora Labs in a US$ 23 million Series B financing round

Read More
HIGH TECH

Representation of Medasense Biometrics Ltd. in a US$ 18 million C round worth

Read More
Corporate

Representation of Knafei Nesharim Aviation in the acquisition of control of El Al

Read More